Michal Abrahamowicz
Research Scientist, PhD
Appointments
- James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
- Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre
Research Interests
- Biostatistics
- Survival analysis
- Pharmacoepidemiology
- Clinical epidemiology
- Epidemiologic methods
- Longitudinal analysis
- Non-communicable disease epidemiology
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.
His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).Learn more
Recent News Coverage
What you need to know about biosimilars
On May 27, British Columbia became the first province to expand the use of biosimilars/biogenerics. Find out what this means for the more than 800,000 people in BC living with arthritis.To read our frequently asked questions on biosimilars/biogenerics,...
Arthritis Research Canada opens fourth centre
Arthritis Research Canada, the largest clinical arthritis research institution in North America, continues to grow with its newest centre located at McGill University. Drs. Deborah Da Costa, Michal Abrahamowicz, Susan Bartlett and Marie Hudson will join the new...
Arthritis Research Canada graced by talk of Olympic proportions
On June 28, Nancy Greene Raine, Canada’s Female Athlete of the 20th Century, joined staff and scientists as Arthritis Research Canada’s Distinguished Guest Speaker for the organization’s Annual Retreat. Greene Raine provided an inspirational presentation on her...
Living with arthritis? Learn about biosimilars
What is a biosimilar/biogeneric? Biologics are medicines taken by IV or self-injection and are made up of large protein molecules derived from living cells. There are now two versions of biologics: “originators” and “biosimilars” (also known as...
BC government announces $2 million for arthritis research at ARThritis Soirée
Arthritis Research Canada received exciting news at Wednesday night’s annual ARThritis Soirée – a $2 million funding announcement by Health Minister Adrian Dix. This boosted the event’s fundraising total to an amazing $2,355,000 in support of life-saving...
Canadians support access to health data for research but curious about privacy
An Arthritis Research Canada study has revealed Canadians back the use of de-identified routinely collected data for health research but want to learn more about how their information is protected. Over 93 per cent of individuals who participated in the study felt...
A Conversation with Macdonald Realty’s President
Arthritis Research Canada is honoured to have the support of Macdonald Realty as the 2019 ARThritis Soirée Presenting Sponsor. To find out more about the company and its support of arthritis research, we sat down with Macdonald Realty President, Dan...
Study to investigate connection between vision loss and common arthritis medication
Arthritis Research Canada will examine the connection between hydroxychloroquine (HCQ) and vision loss in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). All systemic lupus erythematosus patients, and a large number of individuals with...
Arthritis Research Canada scientist honoured with prestigious investigator award
Dr. Diane Lacaille to receive accolade for outstanding contributions to rheumatology Arthritis Research Canada’s Associate Scientific Director, Dr. Diane Lacaille, will receive the Distinguished Investigator Award from the Canadian Rheumatology Association on March...
Study finds no link between biologics and serious infection in moms or babies
An Arthritis Research Canada study, published in BMJ Open, has revealed use of biologics by women with autoimmune disease during pregnancy does not increase their risk of serious infections that require hospitalization after giving birth or their infants’ odds of...
